1. Home
  2. UIT
  3. Health Care Portfolio Series 9

Health Care Portfolio Series 9

matured

Investment Objective

The Health Care Portfolio ("Trust") seeks to maximize total return through capital appreciation with a secondary objective of current income.

Principal Investment Strategy

Selection Criteria

Risks and Other Considerations

Portfolio Information

Deposit Information

Inception Date 1/28/2009
Non-Reoffered Date 10/28/2009
Mandatory Maturity Date 1/26/2011
NASDAQ Ticker Symbol CHCRIX
Trust Structure GRANTOR
Inception Unit Price $10.0000
Maturity Price (as of 1/26/11) $11.9642

Past performance is no guarantee of future results. Investment returns and principal value will fluctuate with changes in market conditions. Investors' units, when redeemed, may be worth more or less than their original cost.

This information does not constitute an offer to sell or a solicitation of any offer to buy: nor shall there be any sale of these securities in any state where the offer, solicitation, or sale is not permitted.


Principal Investment Strategy

The Trust consists of 39 stocks classified as being in the Health Care Sector by the Global Industry Classification Standard (“GICS”). The Trust is diversified across the Health Care Sector, which includes the following industries: Biotechnology, Health Care Equipment and Supplies, Health Care Providers and Services, Life Sciences Tools and Services, and Pharmaceuticals. The Sponsor selects stocks for the portfolio that it believes have the potential to achieve the Trust’s investment objective.

Selection Criteria

The Sponsor selects U.S.-traded stocks that it believes are core holdings of a well-diversified health care portfolio. To select the portfolio, the Sponsor follows a very disciplined process that includes both quantitative and qualitative analysis. The Sponsor begins with the approximately 550 stocks of companies that are classified as being in the Health Care Sector, traded on U.S. exchanges, and are either components of the Russell 3000® Index (“R3K”) or have market capitalizations larger than the smallest company within the R3K. The Sponsor then reduces the size of this universe to approximately 250 stocks by performing quantitative screening, which may be primarily based on, but not limited to, the following factors:

  • Valuation. The Sponsor may screen for reasonably valued stocks based on measures such as price-to-earnings, price-to-book, and price-to-cash flow.
  • Growth. The Sponsor may screen for companies with a history of better than average growth of revenues and earnings.
  • Profitability. The Sponsor may screen for companies with a history of consistent and high profitability as measured by return-on-assets, return-on-equity, gross margin and net margin.

The Sponsor then reduces the 250 securities to 39 stocks by performing qualitative analysis, which may be primarily based on, but not limited to, the following factors:

  • Balance Sheet. The Sponsor favors companies which possess overall financial strength and exhibit balance sheet improvements relative to their peers and the marketplace.
  • Industry Leadership. The Sponsor favors companies which possess a strong competitive position among their domestic and global peers.
  • Valuation. The Sponsor favors stocks for which valuations appear to be attractive based on measures such as price-to-earnings, price-to-book, and price-to-cash flow.
  • Growth. The Sponsor favors companies with a history of (and prospects for) better than average growth of revenues and earnings.
  • Profitability. The Sponsor favors companies with a history of (and prospects for) consistent and high profitability as measured by return-on-assets, return-on-equity, gross margin and net margin.

The Russell 3000® Index

The Russell 3000® Index offers investors access to the broad U.S. equity universe representing approximately 98% of the U.S. market. The Russell 3000® is constructed to provide a comprehensive, unbiased, and stable barometer of the broad market and is completely reconstituted annually to ensure new and growing equities are reflected.

Risks and Other Considerations

As with all investments, you may lose some or all of your investment in the Trust. The Trust also might not perform as well as you expect. This can happen for reasons such as these:

  • Stock prices can be volatile. The value of your investment may fall over time. Market value fluctuates in response to various factors. These can include stock market movements, purchases or sales of securities by the Trust, government policies, litigation, and changes in interest rates, inflation, the financial condition of the securities’ issuer or even perceptions of the issuer. Units of the Trust are not deposits of any bank and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.
  • The Sponsor does not actively manage the portfolio. The Trust will generally hold, and may continue to buy, the same securities even though a security’s outlook, market value or yield may have changed.
  • Share prices or dividend rates on the stocks in the Trust may decline during the life of the Trust. There is no guarantee that the issuers of the securities will declare dividends in the future and, if declared, whether they will remain at current levels or increase over time.
  • The Trust includes stocks issued by companies in the health care sector. General risks of companies in the health care sector include extensive competition, generic drug sales or the loss of patent protection, product liability litigation and increased government regulation.
  • The Trust includes securities issued by small-capitalization and mid-capitalization companies. These stocks customarily involve more investment risk than large-capitalization or more seasoned stocks. Small-capitalization and mid-capitalization companies may have limited product lines, markets or financial resources and may be more vulnerable to adverse general market or economic developments.
  • The Trust invests in American Depositary Receipts (“ADRs”). The Trust’s investment in ADRs presents additional risk. ADRs are issued by a bank or trust company to evidence ownership of underlying securities issued by foreign corporations. Securities of foreign issuers present risks beyond those of domestic securities. More specifically, foreign risk is the risk that foreign securities will be more volatile than U.S. securities due to such factors as adverse economic, currency, political, social or regulatory developments in a country, including government seizure of assets, excessive taxation, limitations on the use or transfer of assets, the lack of liquidity or regulatory controls with respect to certain industries or differing legal and/or accounting standards.
  • The Trust may invest in companies that are considered to be passive foreign investment companies (“PFICs”). In general, PFICs are certain non-U.S. corporations that receive at least 75% of their annual gross income from passive sources (such as interest, dividends, certain rents and royalties or capital gains) or that hold at least 50% of their assets in investments producing such passive income. As a result of an investment in PFICs, the Trust could be subject to U.S. federal income tax and additional interest charges on gains and certain distributions with respect to those equity interests, even if all the income or gain is distributed to its unitholders in a timely manner. The Trust will not be able to pass through to its unitholders any credit or deduction for such taxes.
  • Inflation may lead to a decrease in the value of assets or income from investments.

Please see the Trust prospectus for more complete risk information.

Unit Investment Trusts are fixed, not actively managed and should be considered as part of a long-term strategy. Investors should consider their ability to invest in successive portfolios, if available, at the applicable sales charge. UITs are subject to annual fund operating expenses in addition to the sales charge. Investors should consult an attorney or tax advisor regarding tax consequences associated with an investment from one series to the next, if available, and with the purchase or sale of units. Guggenheim Funds Distributors, LLC does not offer tax advice.




Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.

Investing involves risk, including the possible loss of principal.

Guggenheim Investments represents the investment management business of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investments Advisors, LLC ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisors to the referenced funds.

© 2019 Guggenheim Investments. All Rights Reserved.

Research our firm with FINRA Broker Check.

• Not FDIC Insured • No Bank Guarantee • May Lose Value

This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.